COMPAMED came to a successful end, and we at the WILD Group and PHOTONIC Optical Solutions can look back on an exciting and inspiring exhibition. Our discussions with numerous interested parties and partners centred on innovative approaches to how we, as a technology partner for sophisticated opto-mechatronic products and assemblies, can create real added value for our customers.

Although the character of the exhibition has changed over the years, MEDICA and the associated COMPAMED remain the most important leading trade fairs for medical technology and its supplier industry. This year, we once again had the opportunity to demonstrate our position as an ‘end-to-end’ solution provider: From the design, development and simulation of optical systems to the manufacturing of complex medical products and devices for in-vitro diagnostics, our customers value our ability to offer integrated solutions from a single source.

An increasingly clear change can be seen in the visitor structure at MEDICA: More and more interested parties and suppliers are coming from the APAC region. Numerous project ideas were aimed at overcoming global challenges, such as ensuring low-threshold access to healthcare services for and especially in economically disadvantaged regions. Many of these innovative approaches are based on the cost-efficient combination of artificial intelligence, machine learning and the Internet of Things (IoT), as well as mobile analysis systems that are used in a decentralised manner as part of point-of-care testing. These systems offer the potential to incorporate the WILD Group’s core competences into products and solutions that can contribute to overcoming social challenges on a global level.

This year’s COMPAMED not only brought us exciting new contacts and project ideas, but also reaffirmed our claim to be recognised as the ‘Most Trusted Partner’ by our customers and suppliers. With this momentum, we look forward to the coming year with confidence and look forward to continuing to inspire our prospects, customers and partners within the MedTech community with our comprehensive range of services in new exciting project meetings in 2025.